Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
KA - Kineta, Inc.
Market Cap 19.93M P/E - EPS this Y -10.20% Ern Qtrly Grth -
Income -14.1M Forward P/E -1.35 EPS next Y 4.30% 50D Avg Chg -20.00%
Sales 5.44M PEG - EPS past 5Y - 200D Avg Chg -66.00%
Dividend N/A Price/Book N/A EPS next 5Y - 52W High Chg -86.00%
Recommedations 2.00 Quick Ratio 0.82 Shares Outstanding 10.96M 52W Low Chg 5.00%
Insider Own 29.73% ROA -70.91% Shares Float 6.74M Beta -
Inst Own 11.64% ROE -369.01% Shares Shorted/Prior 95.12K/75.26K Price 2.10
Gross Margin -65.80% Profit Margin -259.08% Avg. Volume 21,791 Target Price 13.50
Oper. Margin -288.92% Earnings Date May 9 Volume 13,493 Change -4.55%
Healthcare | Biotechnology | United States
About Kineta, Inc.

Kineta, Inc. is a clinical-stage biotechnology company with a focus on developing immunotherapies that transform patients' lives. It focuses on developing potentially differentiated immunotherapies that address the challenges with current cancer therapy. The company's immuno-oncology pipeline includes KVA12123, a VISTA blocking immunotherapy in development as a twice weekly monoclonal antibody (mAb) infusion drug. KVA12123 is being evaluated in a Phase 1/2 clinical trial as a monotherapy and in combination with pembrolizumab in patients with advanced solid tumors, including non-small cell lung, ovarian, renal cell carcinoma, head and neck, renal cell, and colorectal cancers. It is also developing anti-CD27 agonist mAb immunotherapy to address the problem of exhausted T cells. The company has collaboration and license agreements with MSD International Business GmbH, Genentech, Inc., FAIR Therapeutics B.V., and GigaGen, Inc. Kineta, Inc. is headquartered in Seattle, Washington.

Kineta, Inc. News
04/08/24 Kineta Reports Initial Clinical Response Data at AACR 2024 of its Ongoing Phase 1/2 VISTA-101 Clinical Trial
03/21/24 Kineta Reports Full Year 2023 Financial Results and Provides Corporate Update
03/12/24 KVA12123 Clears Additional Cohorts in Monotherapy and in Combination Therapy Arms in the Phase 1/2 VISTA-101 Clinical Trial; Initial Clinical Response Data Reported
02/29/24 Kineta Announces Restructuring and Exploration of Strategic Alternatives
02/22/24 Kineta to Present New Preclinical Data on its Anti-VISTA Antibody KVA12123 in Acute Myeloid Leukemia at the AACR Blood Cancer Discovery Symposium
02/14/24 Kineta to Present at Upcoming Investor Conferences
02/07/24 Kineta to Participate in H.C. Wainwright Virtual @Home Fireside Chat Series
01/29/24 KA: Phase I/II Update
01/17/24 Kineta Provides Update on its Ongoing Phase 1/2 VISTA-101 Clinical Trial of KVA12123 in Patients with Advanced Solid Tumors
01/04/24 Kineta to Participate in the 13th Annual LifeSci Partners Corporate Access Event
12/15/23 Life Science Investor Forum: Presentations Now Available for Online Viewing
12/13/23 Kineta Publishes Preclinical Data Demonstrating the Potential of Anti-VISTA Antibody KVA12123 as an Immunomodulatory Therapy for Cancer
12/12/23 Life Science Investor Forum Agenda Announced for December 14th, 2023
12/12/23 Kineta to Present at the Life Sciences Investor Forum December 14th
11/28/23 Kineta to Host KOL Event to Review New Data from VISTA-101 Clinical Trial of KVA12123 in Patients with Advanced Solid Tumors on December 5, 2023
11/09/23 Kineta to Present at the 5th Annual Macrophage-Directed Therapies Summit
11/07/23 KA: Third Quarter Results
11/06/23 Kineta Unveils Positive New Data from VISTA-101 Clinical Trial of KVA12123 at the Society for Immunotherapy of Cancer’s (SITC) 38th Annual Meeting
11/04/23 Kineta Insider Purchases Yet To Pay Off Regardless Of Recent Strength
11/03/23 Kineta Reports Third Quarter 2023 Financial Results and Provides Corporate Update
KA Chatroom

User Image JPecton Posted - 04/25/24

$ELAB I love the set up here! $KA $LAES $ROKU $GOOGL

User Image ButterCapital Posted - 04/25/24

$KA teasing

User Image JPecton Posted - 04/24/24

$KA I still like this set up

User Image Evo13 Posted - 04/24/24

$KA Such a quiet board for the amount of watchers

User Image ChiefOG Posted - 04/23/24

$KA green here

User Image Stocksrunner Posted - 04/22/24

🚀📈 Today's Winners: Started Low, Ended High! 🔥 $VIVK +43.00% 🔥 $PROK +35.32% 🔥 $KA +21.15% 🔥 $LYEL +9.55% 🔥 $NIO +8.70% Exciting market moves! Keep an eye on these winners! 📈🚀

User Image Count_S9 Posted - 04/22/24

@BearishAlgo Great picks, other than $KA I'm short all of those - $KA needs to get close to $1 for me to short

User Image BearishAlgo Posted - 04/22/24

Today's short setups results $KA $VIVK $PHIO $ZCAR

User Image parabolicrunners Posted - 04/22/24

$KA looking good …

User Image JPecton Posted - 04/22/24

$KA I was lucky

User Image DILF32 Posted - 04/22/24

$KA

User Image VrtcIl Posted - 04/22/24

What are your targets on $KA? Closest round level at 1. Take out profits right before those round numbers. Many orders on those levels are waiting to get filled. Price: 0.73 Float: 7.0M Short Float: 0.8 % 💰 Dollar Volume: 44.3K ℹ️ USA | Biotechnology

User Image BearishAlgo Posted - 04/22/24

$KA

User Image ButterCapital Posted - 04/22/24

$KA adding back

User Image LonnieSr1978 Posted - 04/21/24

$KA First stock with 12+k watchers and no one says nothing about it lmao 🤣 like the zombie apocalypse up in here 🤦🏽‍♂️

User Image LonnieSr1978 Posted - 04/19/24

$KA 20k buy LOVE IT 💪🏾😎

User Image LonnieSr1978 Posted - 04/19/24

@AddiLivi Me to but we push on. I found $KA its early 💪🏾

User Image LonnieSr1978 Posted - 04/19/24

@Kfitzg I took a 25 percent loss and called it game. Then I jumped into $KA its early LFG 😎💪🏾

User Image LonnieSr1978 Posted - 04/19/24

$KA Almost 13k watchers and 3 posts a day either I'm early as hell or I'm in the wrong stock lmao 🤣 MAYBE IM EARLY TO THIS PARTY either way I'm sure it will be a fun bumpy ride to the top.

User Image LonnieSr1978 Posted - 04/19/24

$KA Diamond hands LFG

User Image DILF32 Posted - 04/19/24

$KA

User Image reiko85 Posted - 04/19/24

$SPCB $KA $HUBC $LIFW 💪💪💪💪💥💥💥

User Image shared_alerts Posted - 04/19/24

-04/19/2024- 📉 MORNING GAPPERS CONT 📈 $SPCB $KA $HUBC $LIFW ↩️

User Image free_stock_alerts Posted - 04/19/24

$KA buy>.60

User Image RollingDollar Posted - 04/19/24

$KA

User Image ChiefOG Posted - 04/19/24

$KA 👀

User Image Stocksrunner Posted - 04/18/24

🚀 Today's Target Price Updates: Keep Your Eyes Open! 1️⃣ $CSL - Target Up 7.39% to $421.15! 2️⃣ $FSS - Target Raised 5.73% to $84.66! 3️⃣ $GBX - Target Soars 14.29% to $61.20! 4️⃣ $GCT - Target Climbs 14.08% to $41.31! 5️⃣ $KA - Target Jumps 25.58% to $13.77! 💰 Major potential for growth. See all at Target Price Changed https://stocksrunner.com/target

User Image RollingDollar Posted - 04/18/24

$KA

User Image Tshanky_ Posted - 04/18/24

$KA I like what they are doing and recent news, but they have no funding approved, and can’t fund trials. Shareholders voted against it…

User Image cseblessed Posted - 04/18/24

$KA 👀👀

Analyst Ratings
HC Wainwright & Co. Buy Jan 18, 24
HC Wainwright & Co. Buy Aug 21, 23
HC Wainwright & Co. Buy May 18, 23
HC Wainwright & Co. Buy May 1, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Bartoszek Raymond J. Director Director Dec 04 Buy 4.44 2,250 9,990 17,206 12/06/23
PHILIPS CRAIG W. President President Nov 28 Buy 3.2707 3,000 9,812 60,811 11/30/23
Iadonato Shawn Chief Executive Offi.. Chief Executive Officer Nov 28 Buy 3.42 5,000 17,100 675,230 11/30/23
PHILIPS CRAIG W. President President Sep 20 Buy 2.47 3,500 8,645 57,811 09/21/23
Kenny Pauline General Counsel & Se.. General Counsel & Secretary Sep 20 Buy 2.58 1,500 3,870 18,448 09/21/23
Iadonato Shawn Chief Executive Offi.. Chief Executive Officer Sep 20 Buy 2.5042 10,000 25,042 670,230 09/21/23
Bartoszek Raymond J. Director Director Sep 19 Buy 2.3725 2,000 4,745 14,956 09/21/23
Baker Keith Chief Financial Offi.. Chief Financial Officer Sep 18 Buy 2.1345 5,000 10,672 16,880 09/19/23
Bartoszek Raymond J. Director Director Sep 15 Buy 2.13 3,000 6,390 12,956 09/19/23
Guillaudeux Thierry Chief Scientific Off.. Chief Scientific Officer Sep 14 Buy 2.00 10,000 20,000 21,696 09/15/23
PHILIPS CRAIG W. President President Mar 17 Sell 4.68 2,103 9,842 66,977 03/21/23
Kenny Pauline General Counsel & Se.. General Counsel & Secretary Mar 17 Sell 4.48 1,311 5,873 17,806 03/21/23
Iadonato Shawn Chief Executive Offi.. Chief Executive Officer Mar 17 Sell 4.48 2,699 12,092 666,287 03/21/23
Peters Richard President and CEO President and CEO Dec 02 Sell 1.6913 10,890 18,418 90,028 12/06/22
Wyzga Michael D See Remarks See Remarks Dec 02 Sell 1.6913 3,116 5,270 13,997 12/06/22
Epstein Marie Principal Accounting.. Principal Accounting Officer Dec 02 Sell 1.691 1,976 3,341 8,883 12/06/22
Smith Devin Whittemore SVP and General Coun.. SVP and General Counsel Dec 02 Sell 1.691 3,116 5,269 13,961 12/06/22
Epstein Marie Principal Accounting.. Principal Accounting Officer Jun 03 Sell 1.1946 1,806 2,157 10,859 06/06/22
Smith Devin Whittemore SVP and General Coun.. SVP and General Counsel Jun 03 Sell 1.1946 2,923 3,492 17,077 06/06/22
Wyzga Michael D See Remarks See Remarks Jun 03 Sell 1.1946 2,887 3,449 17,113 06/06/22
Peters Richard President and CEO President and CEO Jun 03 Sell 1.1946 10,206 12,192 105,502 06/06/22
Peters Richard President and CEO President and CEO Mar 28 Sell 1.8455 10,715 19,775 115,708 03/30/22